Optimising cardioprotection during myocardial ischaemia: targeting potential intracellular pathways with glucagon-like peptide-1

por Clarke, Sophie J, McCormick, Liam M, Dutka, David P
Publicado 2014

Hyperinsulinemia improves ischemic LV function in insulin resistant subjects

por Heck, Patrick M, Hoole, Stephen P, Khan, Sadia N, Dutka, David P
Publicado 2010

Glucagon-Like Peptide-1: A Promising Agent for Cardioprotection During Myocardial Ischemia

por Giblett, Joel P., Clarke, Sophie J., Dutka, David P., Hoole, Stephen P.
Publicado 2016

Assessment of Myocardial Scar; Comparison Between (18)F-FDG PET, CMR and (99)Tc-Sestamibi

por Crean, Andrew, Khan, Sadia N., Davies, L. Ceri, Coulden, Richard, Dutka, David P.
Publicado 2009

Glucagon-like peptide-1 protects against ischemic left ventricular dysfunction during hyperglycemia in patients with coronary artery disease and type 2 diabetes mellitus

por McCormick, Liam M, Heck, Patrick M, Ring, Liam S, Kydd, Anna C, Clarke, Sophie J, Hoole, Stephen P, Dutka, David P
Publicado 2015

Glucagon-like peptide-1 derived cardioprotection does not utilize a KATP-channel dependent pathway: mechanistic insights from human supply and demand ischemia studies

por Giblett, Joel P., Axell, Richard G., White, Paul A., Clarke, Sophie J., McCormick, Liam, Read, Philip A., Reinhold, Johannes, Brown, Adam J., O’Sullivan, Michael, West, Nick E. J., Dutka, David P., Hoole, Stephen P.
Publicado 2016